After a trial this week, a Boston federal jury has ordered Eli Lilly to pay rival Teva $176.5 million for infringing three patents covering the latter's migraine prevention drug, Ajovy, Reuters reports.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,